SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hardy, C J
Right arrow Articles by Powell, R J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardy, C J
Right arrow Articles by Powell, R J
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Systemic lupus erythematosus (SLE) and hair treatment: a large community based case-control study

C J Hardy

School of Nursing, Education Centre, County Hospital, Lincoln, UK

B P Palmer

Division of Public Health Medicine and Epidemiology, School of Community Health Sciences, University Hospital, Queen's Medical Centre, Nottingham, UK

K R Muir

Division of Public Health Medicine and Epidemiology, School of Community Health Sciences, University Hospital, Queen's Medical Centre, Nottingham, UK

R J Powell

Clinical Immunology Unit, Department of Immunology, University Hospital, Queen's Medical Centre, Nottingham, UK

Objective: To investigate the association of hair treatment, including permanent and non-permanent dyes, bleach, highlights and lowlights on the development of systemic lupus erythematosus (SLE).

Methods: 150 SLE patients and 300 controls from Nottingham, UK were interviewed in a casecontrol study. Controls were matched to cases for gender and year of birth. All patients met at least four of the American Rheumatology Association criteria for SLE. Controls were randomly selected from the Nottingham Family Health Services Authority register. Information was collected via an interview-administered questionnaire concerning demographic variables and hair treatment.

Results: For hair treatment no significant associations were observed between ever using permanent colouring, non-permanent colouring, bleach or lowlights, and disease. Nevertheless a significant association (OR 0.55, 95% CI 0.31–0.95) was observed between ‘ever having’ used highlights and disease with cases having used highlights less frequently than their healthy counterparts. No significant differences were observed in duration of usage of hair bleach, permanent colouring, non-permanent colouring, highlights and lowlights between cases and controls.

Conclusions: Hair treatment or duration of hair treatment usage is not significant in the aetiology of SLE. Although patients with SLE were less likely in this study to have highlights than controls, for all other hair treatments no differences were observed.

Key Words: systemic lupus erythematosus • hair dye • aetiology

Lupus, Vol. 8, No. 7, 541-544 (1999)
DOI: 10.1191/096120399678840800


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
LupusHome page
J Jimenez-Alonso, J M Sabio, F Perez-Alvarez, I Reche, C Hidalgo, L Jaimez, and Grupo Lupus Virgen de las Nieves
Hair dye treatment use and clinical course in patients with systemic lupus erythematosus and cutaneous lupus
Lupus, July 1, 2002; 11(7): 430 - 434.
[Abstract] [PDF]


Home page
Rheumatology (Oxford)Home page
A. A. Bengtsson, L. Rylander, L. Hagmar, O. Nived, and G. Sturfelt
Risk factors for developing systemic lupus erythematosus: a case-control study in southern Sweden
Rheumatology, May 1, 2002; 41(5): 563 - 571.
[Abstract] [Full Text] [PDF]



Advertisement